Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.47 |
| ▸ | GALR3 | O60755 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL500452 | 0.94 | MEN1 (0.46) | MEN1KMT2APDE4DCYP3A4TP53 | |
| SCHEMBL500451 | 0.94 | MEN1 (0.46) | MEN1KMT2APDE4DCYP3A4TP53 | |
| SCHEMBL30368256 | 0.94 | GALR3 (0.47) | MEN1KMT2APDE4DGALR3 | |
| SCHEMBL29094957 | 0.93 | MEN1 (0.45) | MEN1KMT2APDE4DGALR3CYP3A4 | |
| SCHEMBL11087291 | 0.92 | ALDH1A1 (0.45) | MEN1KMT2APDE4DGALR3CYP3A4 | |
| SCHEMBL833101 | 0.89 | GALR3 (0.44) | MEN1KMT2APDE4DGALR3 | |
| SCHEMBL830653 | 0.89 | GALR3 (0.44) | MEN1KMT2APDE4DGALR3 | |
| SCHEMBL6135354 | 0.89 | GALR3 (0.44) | MEN1KMT2APDE4DGALR3 | |
| SCHEMBL14224913 | 0.89 | PDE4D (0.61) | MEN1KMT2APDE4DTP53 | |
| SCHEMBL14224961 | 0.89 | PDE4D (0.61) | MEN1KMT2APDE4DTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119013011-A | AMPK activators (CBDA) and SGLT2 inhibitors for metabolic health | 雀巢产品有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-116981452-A | Substituted resorcinol compounds for the management of aging and related disorders | 雀巢产品有限公司 | 2023-10-31 | — | — | CN | claimed |
| CN-116761791-A | Substituted resorcinol compounds as AMPK activators and uses thereof | 雀巢产品有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-119013011-A | AMPK activators (CBDA) and SGLT2 inhibitors for metabolic health | 雀巢产品有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-116981452-A | Substituted resorcinol compounds for the management of aging and related disorders | 雀巢产品有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116761791-A | Substituted resorcinol compounds as AMPK activators and uses thereof | 雀巢产品有限公司 | 2023-09-15 | — | — | CN | disclosed |